Effects of a Nutraceutical on Cholesterol in Children
Author Information
Author(s): Garoufi Anastasia, Papadaki Maria, Kalogiannis Michalis, Zerva Urania, Charakida Marietta, Marmarinos Antonios, Attilakos Achilleas
Primary Institution: National and Kapodistrian University of Athens
Hypothesis
The study aims to evaluate the efficacy and safety of a dietary supplement containing red yeast rice and other natural compounds in children with primary hypercholesterolemia.
Conclusion
The nutraceutical Armolipid significantly reduced cholesterol levels in children with moderate and severe hypercholesterolemia without adverse effects.
Supporting Evidence
- Nutraceutical consumption resulted in a significant decrease in total cholesterol and LDL cholesterol levels.
- 84 children were evaluated, with 64 having a second evaluation after treatment.
- More than 60% of participants showed a decrease in atherogenic lipoproteins.
- No adverse effects were reported during the study.
- Armolipid may be an effective complementary treatment for children with hypercholesterolemia.
Takeaway
Kids with high cholesterol can take a special supplement that helps lower their cholesterol levels safely.
Methodology
A prospective single-center cohort study was conducted with clinical and laboratory evaluations before and after treatment with the nutraceutical.
Potential Biases
Potential bias due to reliance on self-reported compliance with supplement intake.
Limitations
The study lacked a control group and had a relatively small sample size, which may affect the generalizability of the findings.
Participant Demographics
84 children and adolescents aged 7 to 16 years, with a near-equal gender distribution.
Statistical Information
P-Value
p < 0.001
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website